Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (71-80 of 539) with videos related to

Pageof 54
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Scientific Reports|June 23, 2016
The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic ImplicationsKari Hemminki, Asta Försti, Raimo Tuuminen, et al.
Blood|November 25, 2010
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migrationJerome Moreaux, Dirk Hose, Alboukadel Kassambara, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 22, 2007
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosisFalk-Udo Sack, Arnt Kristen, Hartmut Goldschmidt, et al.
Blood|February 18, 2016
Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibitionMarc S Raab, Nicola Lehners, Jing Xu, et al.
Hematological Oncology|July 8, 2017
Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practiceMarc-Andrea Baertsch, Jens Hillengass, Joanna Blocka, et al.
Frontiers in Genetics|May 30, 2019
Germline Risk Contribution to Genomic Instability in Multiple MyelomaSiegfried Janz, Fenghuang Zhan, Fumou Sun, et al.
Neurochemical Research|July 17, 2016
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility LociChiara Campo, Miguel Inacio Da Silva Filho, Niels Weinhold, et al.
Leukemia & Lymphoma|April 9, 2014
Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplantAleksandar Radujkovic, Michael Hundemer, Christoph Eisenbach, et al.
Plos One|August 4, 2012
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myelomaAlboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
Pageof 54

Showing results (71-80 of 539) with videos related to

Sort By:
Pageof 54
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Scientific Reports|June 23, 2016
The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic ImplicationsKari Hemminki, Asta Försti, Raimo Tuuminen, et al.
Blood|November 25, 2010
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migrationJerome Moreaux, Dirk Hose, Alboukadel Kassambara, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 22, 2007
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosisFalk-Udo Sack, Arnt Kristen, Hartmut Goldschmidt, et al.
Blood|February 18, 2016
Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibitionMarc S Raab, Nicola Lehners, Jing Xu, et al.
Hematological Oncology|July 8, 2017
Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practiceMarc-Andrea Baertsch, Jens Hillengass, Joanna Blocka, et al.
Frontiers in Genetics|May 30, 2019
Germline Risk Contribution to Genomic Instability in Multiple MyelomaSiegfried Janz, Fenghuang Zhan, Fumou Sun, et al.
Neurochemical Research|July 17, 2016
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility LociChiara Campo, Miguel Inacio Da Silva Filho, Niels Weinhold, et al.
Leukemia & Lymphoma|April 9, 2014
Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplantAleksandar Radujkovic, Michael Hundemer, Christoph Eisenbach, et al.
Plos One|August 4, 2012
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myelomaAlboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
Pageof 54